Xpert MTB/RIF False Detection of Rifampin-resistant Tuberculosis from Prior Infection

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2014 Dec 2

PMID 25436783

Citations 6

Authors

J Daniel Kelly

Shou-Yean Grace Lin

Pennan M Barry

Chris Keh

Julie Higashi

John Z Metcalfe

Affiliations

Soon will be listed here.

Citing Articles

Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact.

Van Rie A, Whitfield M, De Vos E, Scott L, da Silva P, Hayes C J Antimicrob Chemother. 2020; 75(5):1123-1129.

PMID: 32016320 PMC: 8453393. DOI: 10.1093/jac/dkz564.

Evaluation of OMNIgene Sputum and Ethanol Reagent for Preservation of Sputum Prior to Xpert and Culture Testing in Uganda.

Ardizzoni E, Orikiriza P, Ssuuna C, Nyehangane D, Gumsboga M, Mugisha Taremwa I J Clin Microbiol. 2019; 58(1).

PMID: 31619525 PMC: 6935912. DOI: 10.1128/JCM.00810-19.

Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.

Kohli M, Schiller I, Dendukuri N, Dheda K, Denkinger C, Schumacher S Cochrane Database Syst Rev. 2018; 8:CD012768.

PMID: 30148542 PMC: 6513199. DOI: 10.1002/14651858.CD012768.pub2.

Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.

Metcalfe J, Makumbirofa S, Makamure B, Sandy C, Bara W, Mason P Int J Tuberc Lung Dis. 2016; 20(7):882-9.

PMID: 27287639 PMC: 4961684. DOI: 10.5588/ijtld.15.0696.

Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?.

Theron G, Venter R, Calligaro G, Smith L, Limberis J, Meldau R Clin Infect Dis. 2016; 62(8):995-1001.

PMID: 26908793 PMC: 4803105. DOI: 10.1093/cid/civ1223.

References

Friedrich S, Rachow A, Saathoff E, Singh K, Mangu C, Dawson R . Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. Lancet Respir Med. 2014; 1(6):462-70. DOI: 10.1016/S2213-2600(13)70119-X. View

Boyles T, Hughes J, Cox V, Burton R, Meintjes G, Mendelson M . False-positive Xpert® MTB/RIF assays in previously treated patients: need for caution in interpreting results. Int J Tuberc Lung Dis. 2014; 18(7):876-8. DOI: 10.5588/ijtld.13.0853. View

Jureen P, Engstrand L, Eriksson S, Alderborn A, Krabbe M, Hoffner S . Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology. J Clin Microbiol. 2006; 44(6):1925-9. PMC: 1489404. DOI: 10.1128/JCM.02210-05. View

. Availability of an assay for detecting Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use - United States, 2013. MMWR Morb Mortal Wkly Rep. 2013; 62(41):821-7. PMC: 4585342. View

Van Rie A, Mellet K, John M, Scott L, Page-Shipp L, Dansey H . False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications. Int J Tuberc Lung Dis. 2012; 16(2):206-8. PMC: 3680645. DOI: 10.5588/ijtld.11.0395. View

Lin S, Rodwell T, Victor T, Rider E, Pham L, Catanzaro A . Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens. J Clin Microbiol. 2014; 52(2):475-82. PMC: 3911348. DOI: 10.1128/JCM.01821-13. View

Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E . Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax. 2005; 60(2):130-5. PMC: 1747303. DOI: 10.1136/thx.2004.026922. View

Porco T, Oh P, Flood J . Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006. Clin Infect Dis. 2012; 56(6):761-9. PMC: 3657489. DOI: 10.1093/cid/cis989. View

Hsu A, Lee J, Chiang C, Li Y, Chen L, Lin C . Diabetes is associated with drug-resistant tuberculosis in Eastern Taiwan. Int J Tuberc Lung Dis. 2012; 17(3):354-6. DOI: 10.5588/ijtld.11.0670. View

10.

Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K . Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2009; 48(1):229-37. PMC: 2812290. DOI: 10.1128/JCM.01463-09. View

11.

Kennedy N, Gillespie S, Saruni A, Kisyombe G, McNerney R, Ngowi F . Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis. J Infect Dis. 1994; 170(3):713-6. DOI: 10.1093/infdis/170.3.713. View

12.

Lippincott C, Miller M, Popowitch E, Hanrahan C, Van Rie A . Xpert MTB/RIF assay shortens airborne isolation for hospitalized patients with presumptive tuberculosis in the United States. Clin Infect Dis. 2014; 59(2):186-92. PMC: 4133562. DOI: 10.1093/cid/ciu212. View